Manuscript Number : IJSRST2296105
Calcium Signaling in Neurodegeneration : A Review
Authors(1) :-Rijul Mahesh Kharat Neurodegenerative disorders, such as Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), Huntington’s disease (HD), and spinocerebellar ataxias (SCAs), pose a significant medical, social, financial, and scientific challenge. Recent data suggests that many of these illnesses have aberrant neuronal calcium (Ca2+) transmission. Normal aging causes alterations in neuronal Ca2+ signaling that are similar but less drastic. Here, we address the dysregulation of calcium in a number of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. Also noted is the potential effectiveness of Ca2+ blockers in the treatment of various illnesses.
Rijul Mahesh Kharat Calcium Signaling, Dysregulation of calcium, Alzheimer's disease, Parkinson's disease, Huntington's disease, Calcium Blockers
Publication Details
Published in : Volume 10 | Issue 1 | January-February 2023 Article Preview
Hiranandani Foundation School Powai, Mumbai, Maharashtra, India
Date of Publication : 2023-02-28
License: This work is licensed under a Creative Commons Attribution 4.0 International License.
Page(s) : 113-120
Manuscript Number : IJSRST2296105
Publisher : Technoscience Academy
Journal URL : https://ijsrst.com/IJSRST2296105
Citation Detection and Elimination |
|
| Ilya Bezprozvanny, “Calcium signaling and neurodegenerative diseases”, in Trends in Molecular Medicine journal, Vol.15, No.3, doi:10.1016/j.molmed.2009.01.001